| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 12 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | Barth Jay | Chief Medical Officer | Sale+OE | 50,000 | $14.20 | $710,195.00 | -27.8% | |
| Apr 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $13.63 | $272,626.00 | -2.9% | |
| Mar 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $13.60 | $271,979.09 | -1.5% | |
| Feb 25, 2019 | Barth Jay | Chief Medical Officer | Sale+OE | 70,000 | $12.52 | $876,134.00 | -21.2% | |
| Feb 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $12.12 | $242,320.00 | -2.9% | |
| Jan 22, 2019 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 36,000 | $11.81 | $425,134.80 | -13.1% | |
| Jan 16, 2019 | Do Hung | Chief Science Officer | Sale+OE | 53,269 | $12.03 | $641,061.45 | -5.7% | |
| Jan 15, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 103,500 | $11.71 | $1,212,295.50 | -13.4% | |
| Oct 15, 2018 | Baird William D III | Chief Financial Officer | Sale+OE | 10,000 | $12.23 | $122,275.00 | -7.8% | |
| Oct 3, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 50,000 | $12.59 | $629,700.00 | +0.1% |